Does healthcare regime affiliation influence the clinical outcomes of patients with rheumatoid arthritis?

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

Catriona Grigor, Hilary A. Capell, A. Stirling et al. · The Lancet · 2004 · 1.4K citations

Medicine, Clinical Sciences, Internal Medicine +5

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Graeme Jones, Anthony Sebba, Jianhui Gu et al. · Annals of the Rheumatic Diseases · 2009 · 809 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Sample size calculation

Supriya Bhalerao, Prashant Kadam · International Journal of Ayurveda Research · 2010 · 762 citations · Full text

Natural Sciences, Marine Biology, Marine Sciences +15

Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

Mark C. Genovese, Joan M. Bathon, Richard W. Martin et al. · Arthritis & Rheumatism · 2002 · 733 citations

Medicine, Clinical Sciences, Pharmacotherapy +13